GM-CSF as adjuvant for immunotherapy with bispecific antibodies.
Elsässer
D
D
Department of Urology, University of Erlangen-Nürnberg, Germany.
Stadick
H
H
van de Winkel
J G
JG
Valerius
T
T
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D018033:Antibodies, Bispecific; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor